Follow
Vanessa D Jonsson
Vanessa D Jonsson
Verified email at ucsc.edu - Homepage
Title
Cited by
Cited by
Year
Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A
AA Chaudhuri, AYL So, A Mehta, A Minisandram, N Sinha, VD Jonsson, ...
Proceedings of the National Academy of Sciences 109 (11), 4233-4238, 2012
1702012
Project golden gate: Towards real-time java in space missions
D Dvorak, G Bollella, T Canham, V Carson, V Champlin, B Giovannoni, ...
Seventh IEEE International Symposium onObject-Oriented Real-Time Distributed …, 2004
512004
Programming with non-heap memory in the real time specification for Java
G Bollella, T Canham, V Carson, V Champlin, D Dvorak, B Giovannoni, ...
Companion of the 18th annual ACM SIGPLAN conference on Object-oriented …, 2003
502003
Diversity in immunogenomics: the value and the challenge
K Peng, Y Safonova, M Shugay, AB Popejoy, OL Rodriguez, F Breden, ...
Nature methods 18 (6), 588-591, 2021
482021
A scalable formulation for engineering combination therapies for evolutionary dynamics of disease
V Jonsson, A Rantzer, RM Murray
2014 American control conference, 2771-2778, 2014
412014
Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution
VD Jonsson, CM Blakely, L Lin, S Asthana, N Matni, V Olivas, ...
Scientific reports 7 (1), 44206, 2017
372017
CAR T cell therapy progress and challenges for solid tumors
LA Stern, VD Jonsson, SJ Priceman
Tumor Microenvironment, 297-326, 2020
332020
PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages
Y Yamaguchi, J Gibson, K Ou, LS Lopez, RH Ng, N Leggett, VD Jonsson, ...
Journal for immunotherapy of cancer 10 (6), 2022
242022
Reverse Engineering Combination Therapies for Evolutionary Dynamics of Disease: An H∞ Approach
V Jonsson, N Matni, RM Murray
IEEE, Conference on Decision and Control, 2013
222013
A convex optimization approach to cancer treatment to address tumor heterogeneity and imperfect drug penetration in physiological compartments
G Giordano, A Rantzer, VD Jonsson
2016 IEEE 55th Conference on Decision and Control (CDC), 2494-2500, 2016
152016
CAR T cell therapy drives endogenous locoregional T cell dynamics in a responding patient with glioblastoma
VD Jonsson, RH Ng, N Dullerud, RA Wong, J Hibbard, D Wang, B Aguilar, ...
BioRxiv, 2021.09. 22.460392, 2021
62021
Synthesizing combination therapies for evolutionary dynamics of disease for nonlinear pharmacodynamics
V Jonsson, N Matni, RM Murray
53rd IEEE Conference on Decision and Control, 2352-2358, 2014
62014
Advancing T cell–based cancer therapy with single-cell technologies
SL Bucktrout, NE Banovich, LH Butterfield, C Cimen-Bozkus, JR Giles, ...
Nature medicine 28 (9), 1761-1764, 2022
42022
Cellular immunotherapy treatment scheduling to address antigen escape
N Dullerud, VD Jonsson
2020 59th IEEE Conference on Decision and Control (CDC), 4634-4639, 2020
42020
Robust control of evolutionary dynamics
VD Jonsson
California Institute of Technology, 2016
42016
Component-based, run-time flight software modification
M Shahabuddin, A Murray, V Carson
2008 IEEE Aerospace Conference, 1-16, 2008
42008
CAR T cell therapy reshapes the tumor microenvironment to promote host antitumor immune repsonses in glioblastoma
CE Brown, D Alizadeh, V Jonsson, J Hibbard, S Yahn, RA Wong, X Yang, ...
Cancer Research 81 (13_Supplement), 59-59, 2021
22021
OWL for Space Mission Systems development at JPL with semantic architecture styles
NF Rouquette, GM Wasserman, VD Carson
Pasadena, CA: Jet Propulsion Laboratory, National Aeronautics and Space …, 2005
22005
Sensing navigation and reasoning technologies for the darpa urban challenge
M Aly, JW Burdick, V Carson, SD Cairano, L Lindzey, J Ma, RM Murray, ...
Technical Report, Caltech, USA, 2008.[pdf], 2007
12007
Advancing T cell-based cancer therapy with single-cell technologies (vol 28, pg pages1761, 2022)
SL Bucktrout, NE Banovich, LH Butterfield, C Cimen-Bozkus, JR Giles, ...
NATURE MEDICINE, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20